New cholesterol drug shows promise for seniors in 6-Month study
NCT ID NCT07489183
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well the drug atostazet lowers cholesterol and affects blood sugar in people aged 65 and older with high cholesterol. Over 600 participants took the drug for 6 months, and researchers tracked side effects and changes in glucose metabolism. The goal was to confirm the drug's safety and effectiveness in this older population.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
atostazet
What this could lead to
If successful, this could confirm atostazet as a safe and effective option for lowering cholesterol in older adults.
What could go wrong
This is an observational study, not a randomized trial, so results may be less reliable. It only lasted 6 months, so long-term safety and benefits are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Building 1897
Seoul, 04516, South Korea